Brought to you by 
ICU Medical buys Hospira's infusion therapy business from Pfizer; financial terms modified
14 Sep 2020
Executive Summary
Seeking to become a leading global pure play infusion therapy firm, ICU Medical Inc. is paying $1bn--$400mm in its stock and $600mm in cash--to acquire Pfizer Inc.’s Hospira Infusion Systems business.
Deal Industry
- Medical Devices
-
Medical Devices
- Infusion Therapy Equipment and Supplies
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ICU Medical buys Hospira's infusion therapy business from Pfizer; financial terms modified
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice